Skip to main content
Fig. 2 | The Journal of Headache and Pain

Fig. 2

From: Relative efficacy of lasmiditan versus rimegepant and ubrogepant as acute treatments for migraine: network meta-analysis findings

Fig. 2

Network diagrams: base case analysis for pain freedom at 2 hoursa (12 randomised controlled trials). aAssessed using Bayesian fixed-effects model adjusted for baseline risk (36 observations; residual deviance = 36.26). Lines are weighted according to the number of studies comparing the two treatments, and the radius of the circle indicates the number of studies within a given treatment arm

Back to article page

The Journal of Headache and Pain

ISSN: 1129-2377

Contact us